Evidence map›Paper›PMID 42076898›Full record

ArticleAdvanced biology2026

Copper Overload Affects α-Synuclein Clearance Mechanisms in a Parkinson's Disease In Vitro Model.

Debora Musarò, Marina Damato, Chiara Coppola, Marco Greco, Michele Maffia

Abstract read
In one paragraph

Article in Advanced biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Debora MusaròLaboratory of Clinical Proteomic, "V Fazzi" Hospital, Lecce, Italy.
Marina DamatoLaboratory of General and Human Physiology, Department of Experimental Medicine, University of Salento, Lecce, Italy.ORCID https://orcid.org/0000-0003-0104-4323
Chiara CoppolaLaboratory of General and Human Physiology, Department of Experimental Medicine, University of Salento, Lecce, Italy.
Marco GrecoLaboratory of Clinical Proteomic, "V Fazzi" Hospital, Lecce, Italy.
Michele MaffiaLaboratory of Clinical Proteomic, "V Fazzi" Hospital, Lecce, Italy.ORCID https://orcid.org/0000-0003-0665-4534

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease (PD) is a common neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta and the formation of Lewy bodies, abnormal protein aggregates primarily composed of α-synuclein. Copper, an essential trace element, plays a role in α-synuclein aggregation and PD pathogenesis. This study examines the effects of copper overload on α-synuclein clearance pathways, focusing on autophagy and the ubiquitin-proteasome system (UPS) in dopaminergic SH-SY5Y neuroblastoma cells. Copper exposure enhances autophagosome formation, as indicated by increased Beclin-1 and LC3-II levels, and impairs autophagic flux, evidenced by LC3-II accumulation in the presence of chloroquine. Concurrently, copper increases polyubiquitinated proteins, suggesting UPS dysfunction, which is confirmed through MG132 treatment. These disruptions lead to the accumulation and aggregation of α-synuclein, particularly in its phosphorylated form. Immunofluorescence reveals neurite-localized α-synuclein aggregates, consistent with copper's role in α-synuclein pathology. This study highlights copper dyshomeostasis as a contributor to impaired α-synuclein clearance through autophagy and UPS dysfunction, advancing the understanding of PD's molecular basis.

Indexed as

alpha-SynucleinCopperParkinson DiseaseAutophagyCell Line, TumorDopaminergic NeuronsHumansProteasome Endopeptidase ComplexUbiquitinalpha-SynucleinCopperProteasome Endopeptidase ComplexUbiquitinalpha‐synucleinautophagycopperParkinson's disease

Identifiers

PMID42076898
PMCPMC13136777

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.